Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. - Wikidata - wikimedia - TriplyDB

Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.

Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.

http://www.wikidata.org/entity/Q37322643

about

NAA-weighted imaging of the human brain using a conventional readout gradient.Proton MRS in mild cognitive impairment.Quantitative (31)P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance imaging and magnetic resonance spectroscopy in dementias 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.An artificial immune-activated neural network applied to brain 3D MRI segmentation Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study.Biological and clinical MRS at ultra-high field.Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy.Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer.Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.Method to correlate 1H MRSI and 18FDG-PET.Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.1H magnetic resonance spectroscopy in dementia.Alzheimer's disease and other dementing conditions.Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain 1H MR spectroscopy in common dementias Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial.Robust analysis of short echo time (1)H MRSI of human brain Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse.Reduced hippocampal volume and n-acetyl aspartate in posttraumatic stress disorder.Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies.

P2860

Q30558437-8E783A57-260F-4514-8845-4B8A100704A7 Q30606675-DCD74700-5389-4AD8-9C69-D04275D1B708 Q30624011-F0316E3B-7EC1-4E1B-9B7E-B9F49A09593D Q30630699-5FE9C85A-20C2-4937-B622-04E77A05AADE Q30660816-153EC297-88BA-485D-8AE5-57B8CADD7C52 Q30945792-162EC830-4826-428E-AE55-7B849D4603F5 Q30983010-2009EA34-9985-4707-9EC1-9D795D3ACF3D Q31139531-46982B2C-5A81-4C33-A57C-3DA636A35F70 Q31993875-72DCE168-87AB-4C79-A5AA-72F2D37E1740 Q32068002-100F1CB3-1C44-43C3-AE19-8564CAC34AB6 Q32139202-F937214A-10BD-43A7-BB8C-A36DF95F89CE Q34247831-0DF587AE-0CE5-4644-8F81-6DF8AF4B7446 Q35572392-4643DEC6-CCB2-4D35-96C6-9558C2B23863 Q35677174-96F24512-82F6-48FD-A3F4-053042B0F566 Q35677181-409EC837-152F-4F55-8B20-FE359281C625 Q35749793-3EA97392-64D2-43AC-8BB3-83EB4F95A472 Q35781558-4D6A7013-21AC-4AC5-B6F7-3DEFF71AEF85 Q35880623-B096FD34-2A96-4A1A-81C9-52FC09A094BD Q35933438-3DE491A3-53E0-409E-A15D-13D4C711E8D4 Q36012768-A25C3710-B6F0-43BB-9E3F-2F9E405262C7 Q36098778-E937D44E-3EE2-4696-8239-0F7100F9E035 Q36257224-C1AA6CBE-5447-470D-8D3B-E8F2F39EB15A Q37150637-4B97015A-F765-44BB-844E-64B581D150DF Q37305458-61A66C03-0190-4AC9-8F92-24AC050A5BF7 Q37322588-0E12F63E-DC6B-461B-92BE-ED1F0A4BAA5F Q37358672-4E4F33E1-A0D0-4F29-AE47-6C225AEFCA0D Q37365638-3A3C81F6-A81F-4B6C-B20F-AA1FAAA10B79 Q37398605-5582AFD1-006F-42BC-967D-7AF00E2891F2 Q37398634-0CA0185E-8D3A-456E-B489-84D2C6124FF5 Q37407266-C3B0D02F-AF98-4540-A8A8-A84EF0C797DD Q37652823-5E01377C-97E7-4EC1-B96A-F5F7DD5918DA Q41197002-47949344-11F7-44D1-B36D-123E0B62CADE Q41996764-0FD3AAD6-818C-41A2-BDD6-2AE33EA604F0 Q42126269-1C4892EF-E1AF-4291-81DA-32B55D6A07D0 Q42561037-211E02C8-0924-4FAA-BB7F-E6B448487D6B Q43798735-37AD01B3-F2F1-41A6-B460-43F991836A12 Q45265084-90CBA5BA-2EB0-4674-963A-10FE27B16563 Q45732943-E132BB14-BE64-45C7-B4A2-0D3B130E2239 Q46708016-02857E64-1669-4DCB-B5F9-10E0FAFF20F6

P2860

Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.

http://www.wikidata.org/entity/Q37322643

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@en

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@nl

type

label

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@en

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@nl

prefLabel

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@en

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@nl

P1433

Q37322643-7E360720-EDBF-48CD-8E51-40525AE9B9A3

P1476

Q37322643-7A00F272-59C7-4E26-B916-5F9F32B5D20D

P2093

Q37322643-2BA0044A-9ED1-4B71-B4F9-21BCF7C97958

Q37322643-3AE0C387-79C6-438E-9004-FE69374D3702

Q37322643-561F06B2-777B-4E32-A7CE-97A63CD0A267

Q37322643-5AE96FD5-B2DF-487D-8790-0974BD9945AB

Q37322643-76B086F0-D7A9-4231-8AAB-A0FEAAAE810B

Q37322643-A2CB048D-DF58-49E0-81C0-CD0D992692AB

Q37322643-B25DD1E3-5A4E-4690-8CE8-C5A1F03E27F4

Q37322643-E3C9484E-4F37-4F44-BE38-E7A90109DAEF

P2860

Q37322643-0A0CF4CE-CEC6-4267-8ED0-6170D25F22DC

Q37322643-0EA6F2E1-A384-4B22-BFA0-62883DB4A01C

Q37322643-0EC1AE58-0C57-4C28-828B-E075D49B6D8A

Q37322643-1437C498-86A9-4023-8360-C077D175DEB9

Q37322643-216E81A2-9E57-4C88-A111-2C808D67A4FA

Q37322643-23AEFA8A-EE00-41B0-8C40-412AFB9F39E7

Q37322643-2B81CC4F-E7B9-41A0-BC62-F37DF20BF6AB

Q37322643-37C82E5B-0FFE-4AA1-A636-30129808BAB4

Q37322643-39A5DFB9-FE1A-47D8-A03F-A58EFD3FA13F

Q37322643-4073B3D9-17B4-466C-8FF1-2625A16867C1

P304

Q37322643-E0BED988-C9CD-4EB3-9201-2DDE69A75E19

P31

Q37322643-DB08292C-344B-49A0-900A-3D1797F87D18

P356

Q37322643-43491665-6214-4730-AF45-7260C6AC4D5B

P407

Q37322643-1EEAD037-8A86-441A-A754-86671508B515

P433

Q37322643-B9A5337E-CAD3-4553-BBD2-3E0A58C35C4D

P478

Q37322643-7B1DAD69-5954-437B-8C74-7D9ADB6B75D6

P577

Q37322643-2E1C6697-C933-41A5-BF40-5B7CF51CE62A

P5875

Q37322643-01406FAF-E27E-475C-A00D-5D98122B74F1

P698

Q37322643-5EBA54D5-8460-405D-AD09-7FB280126D79

P921

Q37322643-6D6F5E54-9F36-4D1C-AF8F-9FF30CC03D6F

Q37322643-704DB6D1-2317-455D-9F8C-0AE471DAF5BA

P932

Q37322643-555A711F-C32E-44A7-ABE6-7CC03C7EE93A

P356

RADIOLOGY.198.2.8596863

P1433

P1476

Alzheimer disease and subcorti ...... H-1 MR spectroscopic imaging.

@en

P2093

D J Meyerhoff

http://www.w3.org/2001/XMLSchema#string

D Norman

http://www.w3.org/2001/XMLSchema#string

F Ezekiel

http://www.w3.org/2001/XMLSchema#string

G Fein

http://www.w3.org/2001/XMLSchema#string

J Gerson

http://www.w3.org/2001/XMLSchema#string

M W Weiner

http://www.w3.org/2001/XMLSchema#string

S MacKay

http://www.w3.org/2001/XMLSchema#string

V Di Sclafani

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Spectroscopic imaging display and analysis.

Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients

Effect of white matter disease on functional connections in the aging brain

Brain atrophy and cognitive function in older abstinent alcoholic men.

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.

Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia.

Alzheimer disease: measuring loss of cerebral gray matter with MR imaging.

Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging.

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

P304

537-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOLOGY.198.2.8596863

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P577

1996-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14603414

http://www.w3.org/2001/XMLSchema#string

P698

8596863

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2733362

http://www.w3.org/2001/XMLSchema#string